MoCA Cognition is a research and innovation-focused company that specializes in delivering the next generation of cognitive screening solutions. Founded by Dr. Ziad Nasreddine, a board-certified neurologist, MoCA Cognition aims to provide comprehensive cognitive screening tools to support clinical settings.

Their flagship product is the MoCA Test, a brief 30-question assessment that helps healthcare professionals detect cognitive impairments at an early stage, enabling faster diagnosis and patient care. The MoCA Test is renowned for its sensitivity in detecting Alzheimer's disease and measuring executive functions and multiple cognitive domains not captured by other tests. MoCA Cognition also conducts extensive research through MoCA Research & Innovation, hosting clinical trials that test the efficacy of novel treatments for Alzheimer's disease and mild cognitive impairment.

Their high-volume MoCA Clinic offers consultation, supportive treatment, and access to research studies for patients with memory complaints or early diagnosed Alzheimer's disease. With a global reach, MoCA Cognition's products, including digital and paper versions of the MoCA Test, are available in over 100 languages and dialects. They are dedicated to advancing cognitive screening and improving patient outcomes in the field of neurology